Reflecting on the strength of the community and engagement, Dr. Chaubey said, “Symposium 2026 is a living example of turning possibility into reality – a community united by the desire to be among the ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled OGM Making its Mark in Constitutional Genetic Disorders. Presentations highlighted how ...

The Phase 1 study is a randomized, double-blind, placebo-controlled, dose-escalation trial carried out in China, designed to ...

Due to the remarkable success of the Research Topic '<a href=" in Pathology of Infectious Diseases' and the rapidly evolving ...

Neurodegenerative disorders such as Alzheimer's disease (AD) are typically diagnosed after irreversible pathology has developed. Aging, the strongest risk factor, drives molecular changes that ...

Neurodegenerative disorders such as Alzheimer's disease (AD) are typically diagnosed after irreversible pathology has ...

When the performance of AI models was assessed within stratified patient subgroups, such as only high-grade breast cancers or ...

Explore how proteomics enables personalized medicine by improving patient stratification, treatment response, and diagnostics ...

Scientists have uncovered the precise molecular trigger behind a rare blood-clotting disorder linked to certain COVID-19 ...

A new national coalition of health, advocacy and research organisations – HPV Network Ireland – has officially launched today ...

Cardiovascular disease remains the leading cause of mortality worldwide, necessitating deeper insights into its molecular ...

Explore how proteomics in biomarker discovery accelerates diagnostic assay development and improves clinical validation.